• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

    4.595 +0.185 (+4.20%)
    Streaming Delayed Price Updated: 12:39 PM EST, Feb 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,210,714
    Open 4.600
    Bid (Size) 4.590 (800)
    Ask (Size) 4.600 (1,200)
    Prev. Close 4.410
    Today's Range 4.440 - 4.700
    52wk Range 1.050 - 6.020
    Shares Outstanding 64,465,037
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Taysha Gene Therapies, Inc.
    Via GlobeNewswire
    News headline image
    Taysha Gene Therapies Inc (NASDAQ:TSHA) Stock Slumps on Q3 Revenue Miss Despite Key Regulatory Win for TSHA-102 ↗
    Taysha Gene Therapies stock fell after Q3 results, with a revenue miss overshadowing positive FDA Breakthrough Therapy designation for its Rett syndrome drug. 
    Via Chartmill

    Performance

    YTD
    -12.5%
    -12.5%
    1 Month
    -12.6%
    -12.6%
    3 Month
    +17.2%
    +17.2%
    6 Month
    +63.5%
    +63.5%
    1 Year
    +171.9%
    +171.9%

    More News

    Read More
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    What's Next: Taysha Gene Therapies's Earnings Preview ↗
    Via Benzinga
    News headline image
    Where Taysha Gene Therapies Stands With Analysts ↗
    Via Benzinga
    News headline image
    Why Is Taysha Gene Therapies Stock Falling Friday? ↗
    Via Benzinga
    News headline image
    Taysha Gene Therapies Stock Soars To 3-Year High After FDA Boost — Wall Street Calls Rett Drug ‘Derisked’ And Ahead Of Rivals ↗
    Via Stocktwits
    News headline image
    Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews ↗
    Via Benzinga
    News headline image
    Discover the most active stocks in Thursday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    News headline image
    Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy ↗
    Via Stocktwits
    News headline image
    Which stocks are gapping on Thursday? ↗
    Via Chartmill
    News headline image
    Top 2 Health Care Stocks That May Keep You Up At Night This Month ↗
    Via Benzinga
    News headline image
    What's Driving the Market Sentiment Around Taysha Gene Therapies? ↗
    Via Benzinga
    News headline image
    Is Taysha Gene Therapies Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts ↗
    Via Benzinga
    News headline image
    Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock ↗
    Via Benzinga
    News headline image
    Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For August 12, 2025 ↗
    Via Benzinga
    News headline image
    Why Is Taysha Gene Therapies Stock Trading Higher On Thursday? ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
    Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
    What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
    Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
    The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
    What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
    The current price of Taysha Gene Therapies, Inc. - Common Stock is 4.595
    When was Taysha Gene Therapies, Inc. - Common Stock last traded?
    The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 02/06/26 12:39 PM ET
    What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
    The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 296.22M
    How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
    Taysha Gene Therapies, Inc. - Common Stock has 296M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.